Medical researchers are developing a treatment for a frequent side-effect of Parkinson’s disease drugs using a corrective RNA molecule to reverse the condition. . . . → Read More: RNA Therapy Studied for Parkinson’s Side Effects
|
|||||
|
|
Yesterday, we reported on 2018 being a banner year for venture capital, but the New York Times says a movement of entrepreneurs is looking for other ways to raise money. . . . → Read More: Start-Ups Saying No Thanks to Venture Capital 
Venture funding last year totaled $99.5 billion, the largest annual outlay since 2000. . . . → Read More: Infographic – Venture Finance Reaching Dot-Com Levels 
A company spun-off from a university medical materials lab received start-up funds to develop a non-opioid surgical pain therapy, including a clinical trial. . . . → Read More: Spin-Off Gains Seed Funds for Non-Opioid Pain Drug 
A developer of therapies derived from cannabis is sponsoring a 3-year basic and translational research program, including clinical trials, at Imperial College London. . . . → Read More: Start-up Funds Univ. Medical Cannabis Research Drug maker Eli Lilly and Company is acquiring a developer of cancer therapies that target specific genetic alterations rather than tumors in the body. . . . → Read More: Lilly Buys Precision Cancer Company in $8B Deal 
We’ll check in from time to time on the Nasdaq Biotechnology Index that tracks 223 biotech industry stocks. . . . → Read More: Infographic – Nasdaq Biotech Index Recovers 
Several agencies that run or finance labs are closed, due to the lapse of funding for about a quarter of federal departments that began on 22 December. . . . → Read More: Govt. Shutdown Disrupts U.S. Science  Comments are closed  Finance, Regulations  biomedical, FDA, grant, life sciences, NASA, NSF, physical sciences 
CB Insights recently issued its annual Tech IPO Report, showing the number of initial public stock offerings in the technology industries unchanged from 2017. . . . → Read More: Infographic – Tech IPOs Flat in 2018 
A 2 year-old company using computational techniques to find protein-targeting drugs raised $400 million in new financing, led by the venture funding arm of Softbank. . . . → Read More: Drug Discovery Start-Up Gains $400M Financing Comments are closed Finance biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, life sciences, mathematics, pharmaceuticals, physical sciences, physics, university, venture capital |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||